In different disease settings including cancer, certain subsets of CD4+ T cells have been reported to express FcγRIII, FcγRII, and/or FcγRI; the ligation of these receptors were reported to enhance interferon-gamma production and cytotoxicity in a subset of human CD4+ T-cells (21, 22). This evidence concerns the gene CD4 and cancer.